title: Long-term follow-up of a hemifacial lentigo maligna treated using 5% imiquimod.
authors.affiliation: Department of Dermatology, Roswel Park Cancer Institute, Buffalo, New York 14263, USA. delles@buffalo.edu
authors.forename: Anne M
authors.initials: AM
authors.lastname: Ramsdell
authors.forename: Nathalie
authors.initials: N
authors.lastname: Zeitouni
mesh_terms: D000287:Administration, Topical; D000369:Aged, 80 and over; D000634:Aminoquinolines / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001706:Biopsy; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D005153:Facial Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D018327:Hutchinson's Melanotic Freckle / Q000188:drug therapy* / Q000473:pathology; D000077271:Imiquimod; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod